Bethesda, MD, United States of America

Mahtab Moayeri

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Mahtab Moayeri

Introduction

Mahtab Moayeri is a prominent inventor based in Bethesda, MD, known for her significant contributions to the field of biotechnology. With a total of seven patents to her name, she has made remarkable strides in developing monoclonal antibodies that target anthrax toxins. Her work is crucial in advancing therapeutic and diagnostic methods for anthrax-related diseases.

Latest Patents

Among her latest patents, Moayeri has developed monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin. This invention includes antibodies that bind or neutralize the PA toxin, as well as fragments of these antibodies that retain their binding ability. The invention also encompasses fully human or humanized antibodies, pharmaceutical compositions, and isolated nucleic acids encoding these antibodies. Furthermore, she has created prophylactic, therapeutic, and diagnostic methods utilizing these antibodies and nucleic acids. Another significant patent involves monoclonal antibodies that neutralize anthrax lethal factor (LF), edema factor (EF), and protective antigen (PA). Similar to her previous work, this invention provides antibodies and their fragments, along with pharmaceutical compositions and methods for their application.

Career Highlights

Moayeri is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in cutting-edge research and contribute to public health initiatives.

Collaborations

Some of her notable coworkers include Zhaochun Chen and Robert H. Purcell, with whom she collaborates on various research projects aimed at combating anthrax and other infectious diseases.

Conclusion

Mahtab Moayeri's innovative work in developing monoclonal antibodies has the potential to significantly impact the field of biotechnology and public health. Her contributions are vital in the ongoing fight against anthrax and highlight the importance of research in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…